Joseph K. Belanoff, CEO of Corcept Therapeutics ($CORT), made 27 open market sales of company shares over the past year, totaling $24.9 million. His latest sale occurred on December 1, 2025. Among 11,678 insiders tracked for sales, Belanoff ranks 567th by total value, exceeding the average of $8.6 million across 6 transactions per insider. He reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 25, 2026 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 26198 | $50.07 | 2,918,326.0000 | 119,981,000 | 0.89% | 0.02% |
| Feb. 27, 2026 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | A | Stock Option (right to buy) | 460000 | $0.00 | 460,000.0000 | 119,981,000 | 9999.99% | 0.38% |
| Dec. 24, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | J | Common Stock | 243154 | $0.00 | 2,944,524.0000 | 119,981,000 | 9.00% | 0.20% |
| Dec. 24, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | M | Stock option (right to buy) | 550000 | $0.00 | 0.0000 | 119,981,000 | 100.00% | 0.46% |
| Dec. 24, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | M | Common Stock | 550000 | $3.88 | 3,494,524.0000 | 119,981,000 | 18.68% | 0.46% |
| Dec. 24, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | F | Common Stock | 306846 | $83.59 | 3,187,678.0000 | 119,981,000 | 8.78% | 0.26% |
| Dec. 24, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | G | Common Stock | 243154 | $0.00 | 2,944,524.0000 | 119,981,000 | 7.63% | 0.20% |
| Dec. 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 40000 | $79.77 | 2,701,370.0000 | 119,981,000 | 1.46% | 0.03% |
| Nov. 5, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 10837 | $75.14 | 2,744,960.0000 | 119,981,000 | 0.39% | 0.01% |
| Nov. 5, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 14355 | $74.20 | 2,755,797.0000 | 119,981,000 | 0.52% | 0.01% |
| Nov. 3, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 11218 | $74.08 | 2,770,152.0000 | 119,981,000 | 0.40% | 0.01% |
| Nov. 5, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 3590 | $75.98 | 2,741,370.0000 | 119,981,000 | 0.13% | 0.00% |
| Oct. 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 5616 | $84.29 | 2,815,754.0000 | 119,981,000 | 0.20% | 0.00% |
| Oct. 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 31190 | $85.16 | 2,784,564.0000 | 119,981,000 | 1.11% | 0.03% |
| Oct. 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 3194 | $85.67 | 2,781,370.0000 | 119,981,000 | 0.11% | 0.00% |
| Sept. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 700 | $71.01 | 2,821,370.0000 | 113,480,000 | 0.02% | 0.00% |
| Sept. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 39300 | $70.52 | 2,822,070.0000 | 113,480,000 | 1.37% | 0.03% |
| Aug. 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 17809 | $68.87 | 2,866,816.0000 | 113,480,000 | 0.62% | 0.02% |
| Aug. 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 5446 | $69.65 | 2,861,370.0000 | 113,480,000 | 0.19% | 0.00% |
| Aug. 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 16745 | $67.81 | 2,884,625.0000 | 113,480,000 | 0.58% | 0.01% |
| July 17, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 615 | $73.69 | 2,901,370.0000 | 113,480,000 | 0.02% | 0.00% |
| June 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 12959 | $84.57 | 2,910,393.0000 | 113,480,000 | 0.44% | 0.01% |
| June 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 4881 | $78.42 | 2,937,104.0000 | 113,480,000 | 0.17% | 0.00% |
| June 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 3050 | $79.48 | 2,934,054.0000 | 113,480,000 | 0.10% | 0.00% |
| June 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 2988 | $80.30 | 2,931,066.0000 | 113,480,000 | 0.10% | 0.00% |
| June 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 1820 | $81.33 | 2,929,246.0000 | 113,480,000 | 0.06% | 0.00% |
| June 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 1263 | $82.26 | 2,927,983.0000 | 113,480,000 | 0.04% | 0.00% |
| June 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 4631 | $83.46 | 2,923,352.0000 | 113,480,000 | 0.16% | 0.00% |
| June 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 8408 | $85.01 | 2,901,985.0000 | 113,480,000 | 0.29% | 0.01% |
| May 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 21520 | $73.22 | 2,941,985.0000 | 113,480,000 | 0.73% | 0.02% |
| May 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 18480 | $72.52 | 2,963,505.0000 | 113,480,000 | 0.62% | 0.02% |
| March 31, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 35102 | $94.72 | 2,982,335.0000 | 113,480,000 | 1.16% | 0.03% |
| April 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 350 | $114.71 | 2,981,985.0000 | 113,480,000 | 0.01% | 0.00% |
| March 24, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 1974 | $60.83 | 3,017,437.0000 | 113,480,000 | 0.07% | 0.00% |
| March 3, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | S | Common Stock | 2924 | $60.91 | 3,019,411.0000 | 113,480,000 | 0.10% | 0.00% |
| Feb. 28, 2025 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | A | Stock option (right to buy) | 350000 | $0.00 | 350,000.0000 | 113,480,000 | 9999.99% | 0.31% |
| July 6, 2022 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | G | Common Stock | 348811 | $0.00 | 3,212,752.0000 | 0 | 9.79% | 0.00% |
| July 31, 2024 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | J | Common Stock | 190417 | $0.00 | 3,022,335.0000 | 111,742,000 | 6.72% | 0.17% |
| July 31, 2024 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | G | Common Stock | 190417 | $0.00 | 3,022,335.0000 | 111,742,000 | 5.93% | 0.17% |
| July 6, 2022 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | J | Common Stock | 348811 | $0.00 | 2,831,918.0000 | 0 | 14.05% | 0.00% |
| July 31, 2024 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | M | Common Stock | 450000 | $3.29 | 3,281,918.0000 | 111,742,000 | 15.89% | 0.40% |
| July 31, 2024 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | F | Common Stock | 259583 | $38.67 | 3,022,335.0000 | 111,742,000 | 7.91% | 0.23% |
| July 31, 2024 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | M | Stock option (right to buy) | 450000 | $0.00 | 0.0000 | 111,742,000 | 100.00% | 0.40% |
| Feb. 9, 2024 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | A | Stock option (right to buy) | 500000 | $0.00 | 500,000.0000 | 111,742,000 | 9999.99% | 0.45% |
| Feb. 13, 2023 | CORCEPT THERAPEUTICS INC | $CORT | BELANOFF JOSEPH K | Chief Executive Officer | A | Stock option (right to buy) | 500000 | $0.00 | 500,000.0000 | 115,966,000 | 9999.99% | 0.43% |